Furans
Apexbio Technology LLC CHLORHEXIDINE-DIACETATE-100MG
Chlorhexidine diacetate (CAS No 56-95-1) is a widely researched antimicrobial agent in the biomedical field known for its effectiveness against a broad spectrum of microorganisms Originating from its development as a potent disinfectant its mechanism of action involves disrupting bacterial cell membranes leading to cell death Its in vitro activity is often observed in the nanomolar to low micromolar range demonstrating strong efficacy at relatively low concentrations Chlorhexidine diacetate is commonly utilized in various experimental applications including cell culture studies animal model testing and drug screening assays In these contexts it serves as a benchmark for evaluating antimicrobial effectiveness or as a control compound in comparative studies Experimental concentrations typically depend on the specific research design Its widespread use underscores its importance in understanding microbial resistance and developing new antimicrobial strategies
Aobchem 6-[(Tetrahydro-3-furanyl)oxy]-3-pyridinecarboxaldehyde | 95% | CAS 2293404-57-4 | C10H11NO3 | 1g
6-[(Tetrahydro-3-furanyl)oxy]-3-pyridinecarboxaldehyde | 95% | CAS 2293404-57-4 | C10H11NO3 | 1g
Medchemexpress LLC 2H-indol-2-one, 1,3-dihydro-3-(2-pyridinylmethylene)-(3Z)- | 187325-53-7 | 98.0% | 222.25 g/mol | C14H10N2O | 50MG
GSK-3β inhibitor 1 is a small-molecule inhibitor of glycogen synthase kinase-3 beta (CAS 187325-53-7) with low-nanomolar biochemical potency and reported antidiabetic efficacy in obese streptozotocin-treated rats. The compound is provided as a solid for research use and is soluble in DMSO with recommended storage conditions for powder and solutions.
Medchemexpress LLC Bliretrigine | 1233229-75-8 | 99.4% | C20H24N4O2 | 10MG
Bliretrigine is a small-molecule sodium channel blocker used in research with reported analgesic effects. The product is provided as a white to off-white solid with specified solubility in DMSO and defined storage recommendations for both powder and solution forms.
- Sodium channel blocker with analgesic activity.
- Molecular formula C20H24N4O2.
- Molecular weight 352.43.
- Purity 99.42%.
- Appearance white to off-white solid.
- Soluble in DMSO at 50 mg/mL; may require ultrasonic assistance.
- Store powder at -20°C for up to 3 years or at 4°C for up to 2 years.
- Store in solution at -80°C for up to 6 months or at -20°C for up to 1 month.
Medchemexpress LLC Trovafloxacin (mesylate) | 147059-75-4 | MFCD00913361 | 99.6% | 512.46 g·mol⁻¹ | C21H19F3N4O6S | 100 MG
Trovafloxacin mesylate is the methanesulfonate (mesylate) salt of trovafloxacin, a fluoroquinolone antibiotic used as a research tool compound and analytical reference in microbiological and biochemical studies.
- Fluoroquinolone antibiotic salt suitable for research and analytical applications.
- Broad-spectrum activity against Gram-positive, Gram-negative, and anaerobic bacteria.
- Molecular formula C21H19F3N4O6S and molecular weight 512.46 g·mol⁻¹.
- CAS number 147059-75-4 for precise identification.
- Soluble in DMSO; commonly supplied as a dry powder for laboratory use.
Medchemexpress LLC Batabulin sodium | 195533-98-3 | MFCD22380600 | 99.8% | 393.24 g/mol | C13H6F6NNaO3S | 5 MG
Batabulin sodium is a sodium salt antitumor research compound that covalently and selectively binds specific β-tubulin isotypes, disrupting microtubule polymerization, inducing G2/M cell-cycle arrest, and triggering apoptotic cell death. Supplied as an off-white to light-yellow solid for in vitro and in vivo research applications.
- Covalently binds to a subset of β-tubulin isotypes.
- Disrupts microtubule polymerization and induces G2/M arrest.
- Induces apoptosis in cell-based assays.
- High reported purity (~99.8%).
- Soluble in DMSO; use freshly opened solvent and ultrasonic assistance if needed.
- Store powder at 4°C; in solution store at -80°C for long-term stability.
Medchemexpress LLC Furazolidone | 500 MG
Furazolidone is a monoamine oxidase (MAO) inhibitor with antiproliferative, apoptosis-inducing and differentiation-promoting activities. It may inhibit leukemia fusion protein-mediated bone marrow transformation by upregulating the stability of the tumor suppressor protein p53, and exhibits anti-leukemic activity in acute myeloid leukemia (AML) cell lines.
- Inhibits monoamine oxidase (MAO).
- Demonstrates antiproliferative activity.
- Induces apoptosis.
- Promotes differentiation.
- May inhibit leukemia fusion protein-mediated bone marrow transformation.
- Upregulates stability of tumor suppressor protein p53.
- Exhibits anti-leukemic activity in acute myeloid leukemia (AML) cell lines.
- Suitable for anti-AML research.
Medchemexpress LLC CK2 inhibitor 2 | 2641079-92-5 | 98.5% | C21H17ClN4O2 | 10MG
CK2 inhibitor 2 is a potent, selective, orally active small-molecule inhibitor of casein kinase 2 (CK2) with sub-nanomolar enzymatic potency and documented cellular activity. Supplied as a solid for research use, it includes solubility data for DMSO and recommended storage conditions for powder and solutions.
- Potent CK2 inhibition (IC50 0.66 nM) for biochemical assays.
- Selectable kinase profile with measurable activity against Clk2.
- Cellular activity in multiple cancer cell lines at low micromolar concentrations.
- High purity suitable for biochemical and cell-based studies (98.5%).
- Documented solubility in DMSO and example in vivo formulation options.
- Defined storage recommendations for powder and solvent preparations.